Neck Ultrasound and the Endocrine Surgeon

  • Edward Paloyan
  • Regina P. Walker
  • Ann M. Lawrence


During the course of surgical residency training, the young “apprentice” is taught a number of universal principles which s/he transgresses only at the patients’ peril and their own risk.


Thyroid Nodule Parathyroid Gland Total Thyroidectomy Primary Hyperparathyroidism Fine Needle Aspiration Cytology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Paloyan, E., American Association of Endocrine Surgeons Presidential Address: The Gatekeepers. Surgery 1988; 104:937–9.PubMedGoogle Scholar
  2. 2.
    Walker RP, Paloyan E. The relationship between Hashimoto’s thyroiditis, thyroid neoplasia, and primary hyperparathyroidism. Otolaryngol Clin North Am 1990; 23; 291–302.PubMedGoogle Scholar
  3. 3.
    Al-Jurf A, Esselstyn CB, Crile G. Thyroid lesions in patients with hyperparathyroidism. Int Surg 1979; 64:33–6.PubMedGoogle Scholar
  4. 4.
    Boullon R., DeMoor P. Parathyroid function in patients with hyper-or hypothyroidism. J Clin Endocrinol Metabol 1974; 38:999–1004.CrossRefGoogle Scholar
  5. 5.
    Calandra DB, Shah K, Lawrence AM, et al. Hyperparathyroidism unmasked by the treatment of hypothyroidism secondary to Hashimoto’s thyroiditis. Surgery 1984; 96:1015–8.PubMedGoogle Scholar
  6. 6.
    Laing VO, Frame B, Block MA. Associated primary hyperparathyroidism and thyroid lesions. Arch Surg 1969; 98:708–12.CrossRefGoogle Scholar
  7. 7.
    Lever EG, Refetoff S, Strauss FH, et al. Coexisting thyroid and parathyroid disease: are they related? Surgery 1983; 94:893,900.Google Scholar
  8. 8.
    Lever EG. Primary hyperparathyroidism masked by hypothyroidism. Am J Med 1983; 74:144–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Walker RP, Oslapas R, Ernst K, et al. Hyperparathyroidism induced by hypothyroidism. Laryngoscope 1993; 103:263–8.PubMedCrossRefGoogle Scholar
  10. 10.
    LiVolsi VA, Feind CR. Parathyroid adenoma and nonmedullary thyroid carcinoma cancer. Cancer 1976; 38:1391–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Park H, Perkins OW, Edmondson JW, et al. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131. Thyroid 1994; 4:49.PubMedCrossRefGoogle Scholar
  12. 12.
    Park H. Stunned thyroid after high dose 131 I scanning. J Clin Nucl Med 1992; 17:501.CrossRefGoogle Scholar
  13. 13.
    Park H, Park Y, Zhou X, et al. Detection of thyroid remnant/metastasis without stunning: An ongoing dilemma. Thyroid 1997; 7:277.PubMedCrossRefGoogle Scholar
  14. 14.
    Hall P, Holm L. Late consequences of radioiodine for diagnosis and therapy in Sweden. Thyroid 1997; 7:206.CrossRefGoogle Scholar
  15. 15.
    Franklyn JA Maisonneuve P, et al. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Eng J of Med 1998; 338(11): 712–8.CrossRefGoogle Scholar
  16. 16.
    McHenry C, Jarosz H, Lawrence AM, Paloyan E. Improving postoperative recurrence rates for carcinoma of the thyroid gland. Surgery 1989; 169:429–434.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2000

Authors and Affiliations

  • Edward Paloyan
    • 1
  • Regina P. Walker
    • 2
  • Ann M. Lawrence
    • 2
  1. 1.HinsdaleUSA
  2. 2.Loyola University Medical CenterMaywoodUSA

Personalised recommendations